LUYE PHARMA GROUP LIMITED revenue breakdown overview

LUYE PHARMA GROUP LIMITED revenue for the last year amounted to 6.45 B HKD, the most of which — 2.26 B HKD — came from its highest performing source at the moment, Oncology Drugs, the year earlier bringing 2.35 B HKD. The greatest contribution to the revenue figure was made by China — last year it brought LUYE PHARMA GROUP LIMITED 5.34 B HKD, and the year before that — 5.56 B HKD.